Skip to main content

Table 3 Biopsy-documented cases with glomerular disease by bevacizumab

From: Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer: a case report and review of the literature

Reference

Age (years)/gender

Onset

Proteinuria

Hematuria

LM

IF

EM

Follow-up

4

59/M

9 mo

3.4 g/gCr

ND

Glomerular TMA

ND

FPE

Proteinuria decreased

4

74/M

3 mo

2.7 g/gCr

ND

Glomerular TMA

ND

FPE

Proteinuria decreased

4

56/M

7 mo

0.16 g/day

ND

Glomerular TMA

ND

Focal FPE

Dead shortly thereafter

4

62/M

3 mo

0.5 g/dl

+

Glomerular TMA

IgA, MES

Fibrin, SEn and MES

Proteinuria resolved

4

61/M

5 mo

4.6 g/day

ND

Glomerular TMA

ND

Focal podocyte injuries

ND

4

59/F

9 mo

0.8 g/day

ND

Glomerular TMA

IgA, MES

EDDs, SEn and focally MES

Persistent proteinuria

5

70/M

2 w

6.0 g/gCr

ND

Glomerular TMA

No

ND

Proteinuria decreased

9

59/M

15 mo

6.9 g/day

Glomerular TMA

IgA, MES and capillary

EDDs, sparsely SEn

Proteinuria decreased

10

ND/ND

ND

Nephrotic

ND

Cryo-GN

ND

ND

ND

11

ND/F

ND

Nephrotic

ND

Collapsing GP

ND

ND

ND

12

69/F

3 mo

3.6 g/day

Glomerular TMA + collapsing GP

IgA, capillary

SEn widening without EDDs

Proteinuria decreased

13

71/M

1 mo

9.6 g/day

ND

Focal PGN

C3 and IgM, MES and capillary

EDDs, sparsely SEn

Proteinuria decreased

14

ND/M

3 mo

3.4 g/gCr

ND

Glomerular TMA

ND

ND

ND

14

ND/ND

1 mo

3.2 g/gCr

ND

Glomerular TMA

ND

ND

ND

Present case

64/M

14 mo

3.5 g/day

+

MES PGN + TMA

IgA, MES and capillary

EDDs, MES and SEn

Proteinuria resolved

  1. Foot notes of Table 3.
  2. Onset means the duration form the start of bevacizumab to the appearance of urinary abnormalities.
  3. M, male, F, female, LM, light microscopy, Cr, serum creatinine, IgA, immunoglobulin A, IgM, immunoglobulin M, C3, serum complement component 3, IF, immunofluorescence, EM, electron microscopy, TMA, thrombotic microangiopathy, MES, mesangial, SEn, subendothelial, Cryo-GN, cryoglobulinemic glomerulonephritis, GP, glomerulopathy, PGN, proliferative glomerulonephritis, FPE, foot process effacement, EDDs, electron dense deposits, ND, not documented, mo, month(s), w, week(s).